Puma Biotechnology, Inc. (PBYI) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 297.57M |
| Enterprise Value | 296.48M |
| P/E Ratio | 20.99 |
| PEG Ratio | -0.47 |
| Price/Sales Ratio | 2.51 |
| Price/Book Ratio | 4.14 |
| Enterprise/Revenue | 2.38 |
| Enterprise/EBITDA | 12.16 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | 0.12 |
| Operating Margin | 0.13 |
AD
Management Effectiveness
| Return On Assets | 0.14 |
| Return On Equity | 0.21 |
Income Statement
| Revenue | 228.37M |
| Revenue/Share | 4.54 |
| Gross Profit | 170.21M |
| EBITDA | 53.34M |
| Net Income | 31.11M |
| Diluted EPS | 0.61 |
Balance Sheet
| Total Cash | 93.9M |
| Total Cash/Share | 1.84 |
| Total Debt | 4.82M |
| Total Debt/Equity | 0.03 |
| Current Ratio | 2.91 |
| Book Value Per Share | 2.72 |
Price History
| 52-Week Change | 123.34 |
| 52-Week High | 11.5 |
| 52-Week Low | 4.58 |
| Moving Average 50 Days | 9.61 |
| Moving Average 200 Days | 7.78 |
Statistics
| Average Volume | 320,357 |
| Shares Outstanding | 51.62M |
| % Held by Institutions | 76.19 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
